The current valuation score of Xenon Pharmaceuticals Inc is 8.39, ranking 102 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -13.31, which is -35.77% below the recent high of -8.55 and -46.93% above the recent low of -19.55.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.